Research programme- RNA based therapeutics - Ginkgo Bioworks/Pfizer
Latest Information Update: 21 Nov 2023
At a glance
- Originator Ginkgo Bioworks
- Developer Ginkgo Bioworks; Pfizer
- Class RNA
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Unspecified